Literature DB >> 30258530

Potential of PDE10A Inhibitors as Treatment for Schizophrenia and Other Neurological Disorders.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2018        PMID： 30258530      PMCID： PMC6142062          DOI： 10.1021/acsmedchemlett.8b00341

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  Emerging biology of PDE10A.

Authors:  Lindsay S Wilson; Nicholas J Brandon
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Update on New and Emerging Treatments for Schizophrenia.

Authors:  Ganesh Gopalakrishna; Muaid H Ithman; John Lauriello
Journal:  Psychiatr Clin North Am       Date:  2016-03-04
  2 in total
  1 in total

1.  Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination.

Authors:  Zhiwei Xiao; Huiyi Wei; Yi Xu; Ahmed Haider; Junjie Wei; Shiyu Yuan; Jian Rong; Chunyu Zhao; Guocong Li; Weibin Zhang; Huangcan Chen; Yuefeng Li; Lingling Zhang; Jiyun Sun; Shaojuan Zhang; Hai-Bin Luo; Sen Yan; Qijun Cai; Lu Hou; Chao Che; Steven H Liang; Lu Wang
Journal:  Acta Pharm Sin B       Date:  2021-11-17       Impact factor: 14.903
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.